Impact of trimetazidine on incidence of myocardial injury and contrast-induced nephropathy in diabetic patients with renal dysfunction undergoing elective percutaneous coronary intervention

American Journal of Cardiology

Volumn 114, Issue 3, 2014, Pages 389-394

  Shehata, Mohamed ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; TRIMETAZIDINE; TROPONIN I;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC PATIENT; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE INJURY; HEMODIALYSIS; HUMAN; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TRANSTHORACIC ECHOCARDIOGRAPHY;

CONTRAST MEDIA; CORONARY ANGIOGRAPHY; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY; SURGICAL PROCEDURES, ELECTIVE; TREATMENT OUTCOME; TRIMETAZIDINE; VASODILATOR AGENTS;

EID: 84904249140     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2014.04.052     Document Type: Article

References (27)

1. J.B. Selvanayagam, I. Porto, K. Channon, S.E. Petersen, J.M. Francis, S. Neubauer, and A.P. Banning Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: insights from cardiovascular magnetic resonance imaging Circulation 111 2005 1027 1032
2. J. Herrmann, C. Von Birgelen, M. Haude, L. Volbracht, N. Malyar, H. Eggebrecht, T.F. Konorza, D. Baumgart, and R. Erbel Prognostic implication of cardiac troponin T increase following stent implantation Heart 87 2002 549 553
3. W. Wijns, P. Kolh, N. Danchin, C. Di Mario, V. Falk, T. Folliguet, S. Garg, K. Huber, S. James, J. Knuuti, J. Lopez-Sendon, J. Marco, L. Menicanti, M. Ostojic, M.F. Piepoli, C. Pirlet, J.L. Pomar, N. Reifart, F.L. Ribichini, M.J. Schalij, P. Sergeant, P.W. Serruys, S. Silber, M. Sousa Uva, D. Taggart Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Guidelines on myocardial revascularization Eur Heart J 31 2010 2501 2555
4. Questions and answers on the review of medicines containing trimetazidine (20 mg tablets, 35 mg modified release tablet and 20 mg/ml oral solution). Available at: http://www.ema.europa.eu/docs/en-GB/document-library/Referrals- document/Trimetazidine-31/WC500129195.pdf. Accessed on March 1, 2014.
5. M.D. Cerqueira, N.J. Weissman, V. Dilsizian, A.K. Jacobs, S. Kaul, W.K. Laskey, D.J. Pennell, J.A. Rumberger, T. Ryan, M.S. Verani American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association Circulation 105 2002 539 542
6. A.S. Levey, J. Coresh, T. Greene, L.A. Stevens, Y.L. Zhang, S. Hendriksen, J.W. Kusek, F. Van Lente Chronic Kidney Disease Epidemiology Collaboration Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate Ann Intern Med 145 2006 247 254
7. G.N. Levine, E.R. Bates, J.C. Blankenship, S.R. Bailey, J.A. Bittl, B. Cercek, C.E. Chambers, S.G. Ellis, R.A. Guyton, S.M. Hollenberg, U.N. Khot, R.A. Lange, L. Mauri, R. Mehran, I.D. Moussa, D. Mukherjee, B.K. Nallamothu, and H.H. Ting 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions Circulation 124 2011 2574 2609
8. A.O. Onbasili, Y. Yeniceriglu, P. Agaoglu, A. Karul, T. Tekten, H. Akar, and G. Discigil Trimetazidine in the prevention of contrast-induced nephropathy after coronary procedures Heart 93 2007 698 702
9. R.W. Geenen, H.J. Kingma, and A.J. van der Molen Contrast-induced nephropathy: pharmacology, pathophysiology and prevention Insights Imaging 4 2013 811 820
10. H.S. Thomsen, S.K. Morcos, and B.J. Barrett Contrast-induced nephropathy: the wheel has turned 360 degrees Acta Radiol 49 2008 646 657
11. F. Boccalandro, M. Amhad, R.W. Smalling, and S. Sdringola Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast Catheter Cardiovasc Interv 58 2003 336 341
12. Y. Yenicerioglu, O. YIlmaz, S. Sarioglu, M. Ormen, P. Akan, A. Celik, and T. Camsari Effects of N-acetylcysteine on radiocontrast nephropathy in rats Scand J Urol Nephrol 40 2006 63 69
13. C.W. Hamm, J.P. Bassand, S. Agewall, J. Bax, E. Boersma, H. Bueno, P. Caso, D. Dudek, S. Gielen, K. Huber, M. Ohman, M.C. Petrie, F. Sonntag, M.S. Uva, R.F. Storey, W. Wijns, D. Zahger ESC Committee for Practice Guidelines ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC) Eur Heart J 32 2011 2999 3054
14. M. Pornin, C. Harpey, J. Allal, P. Sellier, and P. Ourbak Lack of effects of trimetazidine on systemic hemodynamics in patients with coronary artery disease: a placebo-controlled study Clin Trials Metaanal 29 1994 49 56
15. D. Grekas, C. Dioudis, G. Papageorgiou, S. Iliadis, C. Zilidis, P. Alivanis, A. Dimitriadou, and A. Tourkantonis Lipid peroxidation after acute renal ischemia and reperfusion in rats: the effect of trimetazidine Ren Fail 18 1996 545 552
16. A. Ozden, Z. Aybek, N. Saydam, N. Calli, O. Saydam, E. Düzcan, and G. Güner Cytoprotective effect of trimetazidine on 75 min warm renal ischemia-reperfusion injury in rats Eur Surg Res 30 1998 227 234
17. E.C. Tsimoyiannis, K.J. Moutesidou, C.M. Moschos, M. Karayianni, S. Karkabounas, and O.B. Kotoulas Trimetazidine for prevention of hepatic injury induced by ischaemia and reperfusion in rats Eur J Surg 159 1993 89 93
18. F.S. Apple, M.M. Murakami, L.A. Pearce, and C.A. Herzog Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease Circulation 106 2002 2941 2945
19. G.J. Merten, W.P. Burgess, L.V. Gray, J.H. Holleman, T.S. Roush, G.J. Kowalchuk, R.M. Bersin, A. Van Moore, C.A. Simonton 3rd, R.A. Rittase, H.J. Norton, and T.P. Kennedy Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial JAMA 291 2004 2328 2334
20. R. Solomon, C. Werner, D. Mann, J. D'Elia, and P. Silva Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents N Engl J Med 331 1994 1416 1420
21. M.A. Stevens, P.A. McCullough, K.J. Tobin, J.P. Speck, D.C. Westveer, D.A. Guido-Allen, G.C. Timmis, and W.W. O'Neill A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. Study. Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation J Am Coll Cardiol 33 1999 403 411
22. M.M. Rahman, S.S. Haque, B. Rokeya, M.A. Siddique, S.K. Banerjee, S.A. Ahsan, F. Rahman, M. Mahmood, K. Ahmed, M.M. Bhuiyan, A.I. Joarder, and R.C. Debnath Trimetazidine in the prevention of contrast induced nephropathy after coronary angiogram Mymensingh Med J 21 2012 292 299
23. W. Kashif, A. Khawaja, S. Yaqub, and S.A. Hussain Clinically significant contrast induced acute kidney injury after non-emergent cardiac catheterization - risk factors and impact on length of hospital stay J Coll Physicians Surg Pak 23 2013 842 847
24. G. Kober, T. Buck, H. Sievert, and C. Vallbracht Myocardial protection during percutaneous transluminal coronary angioplasty: effects of trimetazidine Eur Heart J 13 1992 1109 1115
25. L. Poloński, I. Dec, R. Wojnar, and K. Wilczek Trimetazidine limits the effects of myocardial ischaemia during percutaneous coronary angioplasty Curr Med Res Opin 18 2002 389 396
26. L. Bonello, P. Sbragia, N. Amabile, O. Com, S.V. Pierre, S. Levy, and F. Paganelli Protective effect of an acute oral loading dose of trimetazidine on myocardial injury following percutaneous coronary intervention Heart 93 2007 703 707
27. A. Labrou, G. Giannoglou, D. Zioutas, N. Fragakis, G. Katsaris, and G. Louridas Trimetazidine administration minimizes myocardial damage and improves left ventricular function after percutaneous coronary intervention Am J Cardiovasc Drugs 7 2007 143 150